The DOI matches its Crossref record; the references it cites are not checked yet.
Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment
Open accessAbstract
Cancer stem cells (CSCs) represent a tumor subpopulation responsible for tumor metastasis and resistance to chemo- and radiotherapy, ultimately leading to tumor relapse. As a consequence, the detection and eradication of this cell subpopulation represent a current challenge in oncology medicine. CSC phenotype is dependent on the tumor microenvironment (TME), which involves stem and differentiated tumor cells, as well as different cell types, such as mesenchymal stem cells, endothelial cells, fibroblasts and cells of the immune system, in addition to the extracellular matrix (ECM), different in composition to the ECM in healthy tissues. CSCs regulate multiple cancer hallmarks through the interaction with cells and ECM in their environment by secreting extracellular vesicles including exosomes, and soluble factors such as interleukins, cytokines, growth factors and other metabolites to the TME. Through these factors, CSCs generate and activate their own tumor niche by recruiting stromal cells and modulate angiogenesis, metastasis, resistance to antitumor treatments and their own maintenance by the secretion of different factors such as IL-6, VEGF and TGF-ß. Due to the strong influence of the CSC secretome on disease development, the new antitumor therapies focus on targeting these communication networks to eradicate the tumor and prevent metastasis, tumor relapse and drug resistance. This review summarizes for the first time the main components of the CSC secretome and how they mediate different tumor processes. Lastly, the relevance of the CSC secretome in the development of more precise and personalized antitumor therapies is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CSCs secrete inflammatory factors and cytokines, such as IL-6, IL-4, VEGF, CCL2, and TGF-β, that recruit macrophages to the TME and activate them to become TAMs [97].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [97]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
The citation lists are queued
They are fetched later and appear here then.
References 341 · Cited by 207
Research works printed but not linked: 1
- Yoneura N, Takano S, Yoshitomi H, Nakata Y, Shimazaki R, Kagawa S, et al. Expression of annexin II and stromal tenascin C promotes epithelial to mesenchymal transition and correlates with distant metastasis in pancreatic cancer. Int J Mol Med. 2018;42:821–30.
Metadata
- Authors
- López de Andrés, J., Griñán-Lisón, C., Jiménez, G., & Marchal, J. A.
- Affiliations
- Universidad de Granada (ES)
- Corresponding author
- Jiménez, Gema
- Marchal, Juan Antonio
- Venue
- Journal of Hematology & Oncology
- Published
- 2020-10-15
- Volume
- 13
- Issue
- 1
- Pages
- 136-136
- ISSN
- 1756-8722 (ISSN-L)
- PMC
- PMC7559894
- OpenAlex
- W3093210528
- Cited by
- 207
- References
- 341
- Citations by year
- 2026: 17 · 2025: 18 · 2024: 29 · 2023: 52 · 2022: 53 · 2021: 38
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Journal of Hematology & Oncology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RISalud Institutional Health Repository of Andalucía (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- Institutional Repository of the University of Granada (University of Granada) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Consejería de Salud y Familias de la Junta de Andalucía (PIN-0224-2019)
- Ministerio de Ciencia, Innovación y Universidades (RTI2018-101309-B-C22)
- Consejería de Economía, Conocimiento, Empresas y Universidad de la Junta de Andalucía (SOMM17/6109/UGR)
- Ministry of Economy and Competitiveness, Instituto de Salud Carlos III (PIE16/00045, DTS17/00087)
- Chair "Doctors Galera-Requena in cancer stem cell research" (CMC-CTS963)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- cancer stem cells, secretome, tumor microenvironment, extracellular vesicles, exosomes, tumor niche, angiogenesis, metastasis, drug resistance, tumor recurrence, stromal cells, extracellular matrix, precision oncology, cytokines, vascular endothelial growth factor, TGF-beta, interleukin-6
- MeSH terms
- Animals, Extracellular Matrix, Humans, Interleukins, Neoplasms, Neovascularization, Pathologic, Neoplastic Stem Cells, MicroRNAs, Intercellular Signaling Peptides and Proteins, Exosomes, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment. https://app.cochat.ai/papers/10.1186/s13045-020-00966-3
- The paper
- López de Andrés, J., Griñán-Lisón, C., Jiménez, G., & Marchal, J. A. (2020). Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment. Journal of Hematology & Oncology. https://doi.org/10.1186/s13045-020-00966-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.